Join
Live feed
·
INSIDERFilingvia Quantisnow
Protalix BioTherapeutics Inc. (DE) logo

Director Schwartz Aharon bought $205,884 worth of shares (129,000 units at $1.60), increasing direct ownership by 74% to 303,000 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
PLX· Protalix BioTherapeutics Inc. (DE)
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PLX (Protalix BioTherapeutics Inc. (DE)) and more on Quantisnow.